Showing 1 - 10 of 189
This paper contains an economic and legal analysis of the lawsuit Microsoft vs. U.S. Department of Justice beginning with the District Court's decision on June 7, 2000 up to the Proposed Final Judgement on November 6, 2001. I found that the courts' underlying economic paradigm regarding the...
Persistent link: https://www.econbiz.de/10003958724
In this empirical study all mergers that have been challenged by the U.S. antitrust agencies FTC and DOJ between 1995 and 2008 were analyzed in regard to the question to what extent and how the agencies assessed the innovation effects of mergers. Theoretical background is the still open question...
Persistent link: https://www.econbiz.de/10010404134
Persistent link: https://www.econbiz.de/10012954642
Persistent link: https://www.econbiz.de/10012907038
In this empirical study all mergers that have been challenged by the U.S. antitrust agencies FTC and DOJ between 1995 and 2008 were analyzed in regard to the question to what extent and how the agencies assessed the innovation effects of mergers. Theoretical background is the still open question...
Persistent link: https://www.econbiz.de/10012972734
In the second direct challenge to the NCAA's amateurism rules, the Northern District of California court rejected an attempt by the NCAA and 11 conferences to dismiss claims that defendants violated antitrust law by “conspiring to impose an artificial ceiling on the scholarships and benefits...
Persistent link: https://www.econbiz.de/10012918266
The U.S. Federal Trade Commission opened an investigation into Google's search practices in 2012. The investigation responded to complaints that Google's “Universal Search” display favored its own web properties and demoted competing services. The Commission also investigated Google's...
Persistent link: https://www.econbiz.de/10012933784
We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...
Persistent link: https://www.econbiz.de/10012670921
The Federal Trade Commission (FTC) frequently files complaints against “pay-for-delay” settlements between brand-name pharmaceutical companies and generic-drug manufacturers, the latter of which challenge the monopoly status of patent-protected drugs. I document than when the top 20 generic...
Persistent link: https://www.econbiz.de/10013251907
This paper evaluates the recent literature claiming that the US economy has generally become less competitive causing the US economy to perform poorly and that lax antitrust policy is one important reason for the decline in economic performance. Although there certainly are empirical facts...
Persistent link: https://www.econbiz.de/10012829706